Search results for "REGULATION"

showing 10 items of 4463 documents

A peek inside the neurosecretory brain throughOrthopedialenses

2008

The wealth of expression and functional data presented in this overview discloses the homeogene Orthopedia (Otp) as critical for the development of the hypothalamic neuroendocrine system of vertebrates. Specifically, the results depict the up-to-date portrait of the regulation and functions of Otp. The development of neuroendocrine nuclei relies on Otp from fish to mammals, as demonstrated for several peptide and hormone releasing neurons. Additionally, the activity of Otp is essential for the induction of the dopaminergic phenotype in the hypothalamus of vertebrates. Recent insights into the pathways required for Otp regulation have revealed the implication of the main extracellular signal…

medicine.medical_specialtyNerve Tissue ProteinsBiologyModels Biological03 medical and health sciences0302 clinical medicineInternal medicinemedicineAnimalsHumans030304 developmental biologyHomeodomain Proteins0303 health sciencesDopaminergicBrainGene Expression Regulation DevelopmentalNeurosecretory SystemsPhenotypeDevelopmental dynamicsEndocrinologyHypothalamusFish <Actinopterygii>NeurohormonesNeuroscience030217 neurology & neurosurgeryDevelopmental BiologyDevelopmental Dynamics
researchProduct

Expression pattern of matrix metalloproteinases-2 and -9 and their tissue inhibitors in patients with chronic inflammatory demyelinating polyneuropat…

2021

Background: Matrix metalloproteinases (MMPs) are a heterogeneous family of endopeptidases that play a role in many physiological functions, including the immune response. An imbalance between the activity of MMPs and their physiological tissue inhibitors (TIMPs) has been proposed in the pathophysiology of different autoimmune disorders. We aimed to assess the plasmatic levels of MMP-2, MMP-9, and their inhibitors TIMP-1 and -2 in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Subjects and methods: Twenty patients with CIDP and 20 age- and sex-matched healthy controls were enrolled. Plasma concentrations of MMP-2, MMP-9, TIMP-1, and TIMP-2 were determined by the enzy…

medicine.medical_specialtyNeurologyChronic inflammatory demyelinating polyneuropathyCIDPDermatologyMatrix metalloproteinaseGastroenterologyTissue inhibitor of matrix metalloproteinase03 medical and health sciences0302 clinical medicineImmune systemExpression patternDownregulation and upregulationInternal medicineEndopeptidasesmedicineTIMPHumansIn patient030212 general & internal medicineMMPbusiness.industryGeneral Medicinemedicine.diseaseMatrix MetalloproteinasesPathophysiologyMatrix metalloproteinasePsychiatry and Mental healthMatrix Metalloproteinase 9Polyradiculoneuropathy Chronic Inflammatory DemyelinatingMatrix Metalloproteinase 2Settore MED/26 - NeurologiaNeurology (clinical)business030217 neurology & neurosurgeryNeurological Sciences
researchProduct

Dexamethasone suppresses eNOS and CAT-1 and induces oxidative stress in mouse resistance arterioles

2004

Long-term treatment with glucocorticoids is associated with mild to moderate hypertension. We reported previously that downregulation of endothelial NO synthase (eNOS) expression and activity is likely to contribute to this increase in blood pressure. In the present study, we tested the effects of dexamethasone on the vasodilation of microvascular arterioles using implanted dorsal skin-fold chambers in anesthetized C57BL/6J mice. Experiments were performed on control mice or on mice treated with dexamethasone (0.1–3 mg/kg of body wt). Endothelium-dependent vasodilation in response to ACh (0.1–10 μM) was reduced by dexamethasone in a dose-dependent fashion. Comparable inhibition was seen in …

medicine.medical_specialtyNitric Oxide Synthase Type IIIPhysiologyNitric Oxide Synthase Type IIAscorbic AcidBiologyArgininemedicine.disease_causeAntioxidantsDexamethasoneMicrocirculationMiceDownregulation and upregulationEnosArteriolePhysiology (medical)medicine.arteryInternal medicinemedicineAnimalsHumansGlucocorticoidsCells CulturedNitritesDexamethasoneCationic Amino Acid Transporter 1NitratesMyocardiumEndothelial Cellsbiology.organism_classificationAcetylcholineMice Inbred C57BLVasodilationNitric oxide synthaseArteriolesOxidative StressEndocrinologybiology.proteinVascular ResistanceNitric Oxide SynthaseCardiology and Cardiovascular MedicineOxidative stressGlucocorticoidmedicine.drugAmerican Journal of Physiology-Heart and Circulatory Physiology
researchProduct

Tetralogy of Fallot as a Model to Study Cardiac Progenitor Cell Migration and Differentiation During Heart Development

2009

Tetralogy of Fallot (ToF) has long been considered a congenital disorder that occurs due to environmental alterations during gestation. Recently, several mutated genes have been discovered that are thought to be responsible for the malformations observed in ToF. These genetic mutations, which are microdeletions, are sporadic and are frequently also present in trisomy 21 patients. The ToF malformations can be lethal, but for the last 50 years, surgical repairs that place an artificial patch to repair the four features of ToF have improved the survival of patients with ToF. However, 0.5% to 6% of patients who survive after surgical repair of ToF die of sudden cardiac death caused by ventricul…

medicine.medical_specialtyOrganogenesisBiologyVentricular tachycardiaSudden cardiac deathHomeobox protein Nkx-2.5Cell MovementInternal medicinemedicineAnimalsHumansCell LineageCell ProliferationTetralogy of FallotHomeodomain ProteinsSurgical repairHeart developmentMyocardiumStem CellsGene Expression Regulation DevelopmentalCell DifferentiationToF Cardiac Stem Cellsmedicine.diseaseGATA4 Transcription Factormedicine.anatomical_structureVentricleMutationHomeobox Protein Nkx-2.5Tetralogy of FallotCardiologyCardiology and Cardiovascular MedicineTranscription FactorsCongenital disorderTrends in Cardiovascular Medicine
researchProduct

Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.

2013

Osteoporosis is characterized by low bone mineral density and/or poor bone microarchitecture leading to an increased risk of fractures. The skeletal alterations in osteoporosis are a consequence of a relative deficit of bone formation compared to bone resorption. Osteoporosis therapies have mostly relied on antiresorptive drugs. An alternative therapeutic approach for osteoporosis is currently available, based on the intermittent administration of parathyroid hormone (PTH). Bone anabolism caused by PTH therapy is mainly accounted for by the ability of PTH to increase osteoblastogenesis and osteoblast survival. PTH and PTH-related protein (PTHrP)-an abundant local factor in bone- interact wi…

medicine.medical_specialtyOsteoporosisParathyroid hormoneBone healingBiochemistryBone resorptionBone remodelingOsteogenesisInternal medicinemedicineAnimalsHumansBone regenerationCell ProliferationReceptor Parathyroid Hormone Type 1PharmacologyBone mineralOsteoblastsBone Density Conservation Agentsbusiness.industryParathyroid Hormone-Related ProteinOsteoblastCell Differentiationmedicine.diseaseProtein Structure Tertiarymedicine.anatomical_structureEndocrinologyGene Expression RegulationParathyroid HormoneOsteoporosisFemalebusinesshormones hormone substitutes and hormone antagonistsSignal TransductionBiochemical pharmacology
researchProduct

Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer’s disease

2001

Cholinesterase inhibitors are the only approved drug treatment for patients with mild to moderately severe Alzheimer's disease. Interestingly, the clinical potency of these drugs does not correlate well with their activity as cholinesterase inhibitors, nor is their action as short lived as would be expected from purely symptomatic treatment. A few cholinesterase inhibitors, including galantamine, produce beneficial effects even after drug treatment has been terminated. These effects assume modes of action other than mere esterase inhibition and are capable of inducing systemic changes. We have recently discovered a mechanism that could account, at least in part, for the above-mentioned unex…

medicine.medical_specialtyPatch-Clamp TechniquesReceptors NicotinicPharmacologyCell LineMiceAllosteric RegulationAlzheimer DiseaseInternal medicinemedicineGalantamineAnimalsHumansNootropic AgentsBiological PsychiatryCholinesteraseAcetylcholine receptorNeuronsbiologyGalantamineChemistryNicotinic acetylcholine receptorNicotinic agonistEndocrinologyMechanism of actionTacrinebiology.proteinCholinesterase Inhibitorsmedicine.symptomAllosteric SiteAcetylcholinemedicine.drugBiological Psychiatry
researchProduct

The new frontier of bone formation: a breakthrough in postmenopausal osteoporosis?

2009

Osteoporosis is a chronic disease that accelerates after menopause in many women. Most of the pharmacologic attempts to control the disease, such as hormone therapy, have emphasized the constraint of bone resorption. Since recent years have witnessed important advances in the field of bone formation, this review aims to update the present knowledge on the mechanisms affecting osteoblastogenesis and on the therapeutic results achieved by recently approved drugs.We sought peer-reviewed, full-length basic and clinical articles published between 1995 and May 2008 using a PubMed search strategy, with the terms osteoporosis and osteoblast, osteoporosis and strontium ranelate, and osteoporosis and…

medicine.medical_specialtyPediatricsmedicine.medical_treatmentOsteoporosisThiophenesDiseasePostmenopausal osteoporosisFractures BoneStrontium ranelateOsteogenesisOrganometallic CompoundsmedicineAnimalsHumansBone formationOsteoporosis PostmenopausalAgedOsteoblastsBone Density Conservation Agentsbusiness.industryObstetrics and GynecologyCell DifferentiationGeneral MedicineMiddle Agedmedicine.diseaseSurgeryMenopauseChronic diseaseGene Expression RegulationParathyroid HormoneFemaleHormone therapybusinessmedicine.drugClimacteric
researchProduct

Regulation data for the horizontal jump of children and adolescents

2021

The Horizontal Jump (HJ) is a daily tool that could be used to categorize the level of muscle fitness performance of the lower limbs. The goal was to compare the muscle fitness with those of international studies and to propose percentiles to assess the HJ performance of children and adolescents. A cross-sectional study was conducted. A total number of 3023 children and adolescents between the ages of 6.0 to 17.9 were studied. Weight, height, waist circumference (WC), and lower limb muscle fitness were evaluated. The student HJ performance values in Chile were inferior when compared to HJ performance in Brazil, Poland and Europe. For the Greek study, differences occurred only from age 6 to …

medicine.medical_specialtyPercentile2019-20 coronavirus outbreakWaisthealth promotionlcsh:MedicineArticleLower limbChild healthlcsh:QM1-69503 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationLower limb muscleregulationsmedicineOrthopedics and Sports Medicine030212 general & internal medicineMolecular Biologybusiness.industrylcsh:R030229 sport sciencesCell Biologylcsh:Human anatomyCircumferencehorizontal jumpJumpchild healthNeurology (clinical)business
researchProduct

Effects of cytokines on synthesis and function of the hepatic asialoglycoprotein receptor

1994

In this study we have investigated whether cytokines, critical mediators of the immune response, might have a direct effect on the expression and/or function of the human hepatic asialoglycoprotein receptor (ASGPR). Binding and uptake of asialoglycoproteins by the human hepatoma cell line, HepG2, and by freshly isolated rat hepatocytes were inhibited by 50% after 3-6 hours and completely abolished following a 24 hour exposure to tumor necrosis factor (TNF) alpha, interferon (INF) alpha or gamma, or interleukin-2 (IL-2). The loss of ASGPR binding activity mediated by IL-2 was reversible up to 4 hours of exposure and accompanied by the selective phosphorylation of the cell-surface receptor. S…

medicine.medical_specialtyPhysiologymedicine.medical_treatmentClinical BiochemistryAlpha interferonCell BiologyBiologyCytokineEndocrinologyDownregulation and upregulationAsialoglycoproteinsInternal medicinemedicineInterferon gammaAsialoglycoprotein receptorHepatic Asialoglycoprotein ReceptorReceptormedicine.drugJournal of Cellular Physiology
researchProduct

Additive effect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein A concentrations and…

2013

Objective To analyze whether assisted conceptions need adjustments in first-trimester Down syndrome screening and why modifications in screening markers occur. Design Eleven-year cohort retrospective analysis. Setting Maternal-fetal medicine unit. Patient(s) Two thousand eleven naturally conceived normal singleton pregnancies and 2,042 normal singleton pregnancies achieved with assisted conception: 350 by IUI and 1,692 with IVF (n = 328) or intracytoplasmic sperm injection (ICSI; n=1,364), using nondonor (n = 1,086) or donated ova (n = 606), with fresh (n = 1,432) or frozen (n = 260) embryos. Intervention(s) Comparison of ultrasound and biochemical markers of first-trimester Down syndrome s…

medicine.medical_specialtyPregnancy-associated plasma protein AReproductive Techniques Assistedmedicine.medical_treatmentDown-RegulationFertilization in VitroIntracytoplasmic sperm injectionEmbryo cryopreservationPredictive Value of TestsPregnancyPrenatal DiagnosismedicineHumansPregnancy-Associated Plasma Protein-AChorionic Gonadotropin beta Subunit HumanFalse Positive Reactionsreproductive and urinary physiologyInsemination ArtificialRetrospective StudiesGynecologyDown syndrome screeningAnalysis of VarianceChi-Square DistributionOocyte Donationbusiness.industrySingletonFree βhcgObstetrics and GynecologyPregnancy Trimester FirstReproductive MedicineCohortFemaleHormone therapyDown SyndromebusinessNuchal Translucency MeasurementBiomarkersFertility and sterility
researchProduct